***The International Association for the Study of Pain, RELIEF’s publisher, has just released a position statement on the use of cannabinoids to treat pain (a non-technical version of the position statement is available here).***
The position statement, along with a number of related articles in a special section of the IASP journal PAIN that examines the evidence from animal and human studies on cannabinoids and pain relief, is the output of the IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia. The position statement and related articles are freely available to all.
Will the COVID-19 Pandemic Be Followed by a “Pain Pandemic?”
A recent editorial discussed the future management of chronic pain in people who survive COVID-19 illness.
How Food Triggers the Pain of Irritable Bowel Syndrome
An immune reaction in the colon makes sensory nerves more sensitive.
The Global Burden of Musculoskeletal Disorders: A Data Visualization
Conditions like low back pain and arthritis are among the most common conditions throughout the entire world and are making major contributions to years lived with disability.
High-Impact Chronic Pain: A Data Visualization
Fifty million of US adults have chronic pain and 20 million of US adults have high-impact chronic pain (HICP). Age, sex, education level, employment status, and poverty status are major contributors to HICP